Dr. Darshan Shah

There's a lot of research being done for therapeutics that works, but this is a great way to temporary control.

So I'll tell you what the research shows, and I'll tell you what I think. So the research that Dr. Kiprov did on Alzheimer's patients was a once-a-month treatment. He did that six treatments in a row for six months and measured various markers of symptoms before and after using the MOCA score.

So I'll tell you what the research shows, and I'll tell you what I think. So the research that Dr. Kiprov did on Alzheimer's patients was a once-a-month treatment. He did that six treatments in a row for six months and measured various markers of symptoms before and after using the MOCA score.

So I'll tell you what the research shows, and I'll tell you what I think. So the research that Dr. Kiprov did on Alzheimer's patients was a once-a-month treatment. He did that six treatments in a row for six months and measured various markers of symptoms before and after using the MOCA score.

Exactly. And use other tools as well.

Exactly. And use other tools as well.

Exactly. And use other tools as well.

Give a patient a mocha and see how they like it. So anyhow, he did it once a month for six treatments. Now, that worked for Alzheimer's. What we're seeing in our clinic is probably about the same once every four to six weeks. We're tracking biomarkers, so we're seeing biomarkers change right after the treatment, and change is lasting for six weeks.

Give a patient a mocha and see how they like it. So anyhow, he did it once a month for six treatments. Now, that worked for Alzheimer's. What we're seeing in our clinic is probably about the same once every four to six weeks. We're tracking biomarkers, so we're seeing biomarkers change right after the treatment, and change is lasting for six weeks.

Give a patient a mocha and see how they like it. So anyhow, he did it once a month for six treatments. Now, that worked for Alzheimer's. What we're seeing in our clinic is probably about the same once every four to six weeks. We're tracking biomarkers, so we're seeing biomarkers change right after the treatment, and change is lasting for six weeks.

And then some patients, not all patients, the biomarkers start reverting, okay? And a lot of this has to do with each individual patient's lifestyle. It's the lifestyle, their level of exposure to things like ultra-processed food, lack of sleep, inflammatory lifestyles, And so it really goes patient to patient. And so what I'm a huge advocate of is this whole concept of end of one, right?

And then some patients, not all patients, the biomarkers start reverting, okay? And a lot of this has to do with each individual patient's lifestyle. It's the lifestyle, their level of exposure to things like ultra-processed food, lack of sleep, inflammatory lifestyles, And so it really goes patient to patient. And so what I'm a huge advocate of is this whole concept of end of one, right?

And then some patients, not all patients, the biomarkers start reverting, okay? And a lot of this has to do with each individual patient's lifestyle. It's the lifestyle, their level of exposure to things like ultra-processed food, lack of sleep, inflammatory lifestyles, And so it really goes patient to patient. And so what I'm a huge advocate of is this whole concept of end of one, right?

I don't think there's one particular protocol that applies to everybody. Every patient's an individual biology and psychology, and we need to custom tailor the protocol for each individual patient. So that's kind of where I end up with it. There's a lot of research being done for Alzheimer's and for age-related diseases as well.

I don't think there's one particular protocol that applies to everybody. Every patient's an individual biology and psychology, and we need to custom tailor the protocol for each individual patient. So that's kind of where I end up with it. There's a lot of research being done for Alzheimer's and for age-related diseases as well.

I don't think there's one particular protocol that applies to everybody. Every patient's an individual biology and psychology, and we need to custom tailor the protocol for each individual patient. So that's kind of where I end up with it. There's a lot of research being done for Alzheimer's and for age-related diseases as well.

Well, I don't think it's monthly for everybody. I think that- Because I'm way behind if that's the case. Age-related, I would say, is probably going to end up being quarterly.

Well, I don't think it's monthly for everybody. I think that- Because I'm way behind if that's the case. Age-related, I would say, is probably going to end up being quarterly.

Well, I don't think it's monthly for everybody. I think that- Because I'm way behind if that's the case. Age-related, I would say, is probably going to end up being quarterly.

But once again, it needs to be customized to you, right? So I think for you, if we were to measure your biomarkers, because you live an incredibly healthy lifestyle, of course.